It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
WASHINGTON -- A top U.S. biodefense researcher apparently committed suicide just as the Justice Department was about to file criminal charges against him in the anthrax mailings that traumatized the nation in the weeks following the Sept. 11, 2001, terrorist attacks, according to a published report.
WASHINGTON — For nearly seven years, scientist Bruce Ivins and a small circle of fellow anthrax specialists at Ft. Detrick's Army medical lab lived in a curious limbo: They served as occasional consultants for the FBI in the investigation of the deadly 2001 anthrax attacks, yet they were all potential suspects.
About 10 weeks before 9-11, in June, 2001, senior government officials gathered at Andrews Air Force Base for an extremely complex war game called Dark Winter. One Dark Winter scenario had several major media outlets receiving letters demanding the immediate removal of all U.S. military forces from Saudi Arabia and the waters of the Persian Gulf. The demand is backed by the threat of biological attacks using anthrax, smallpox and plague.Another part of the Dark Winter exercise involved a terrorist smallpox release in Oklahoma City infecting 300,000 people, killing a third in about three weeks. Analysis of the exercise concluded that dealing with the epidemic was impossible due to an inadequate vaccine supply.
In 1998, the BioPort Corporation was founded for the express purpose of buying the Michigan Biologic Products Institute from the State of Michigan. MBPI was the only firm in the U.S. making Anthrax vaccine, and their sole client was the U.S. government. Until recently, BioPort has not been able to deliver any vaccine due to continuous problems with the FDA in areas such as sterility, contamination, as well as improper procedures and record keeping.
BioPort now has on its Board of Directors Admiral William J. Crowe, Jr. In October 1985 Crowe was appointed Chairman of the Joint Chiefs of Staff. He retired from that position in 1989 and was appointed US Ambassador to Britain. Admiral Crowe, a long-time member of the Council on Foreign Relations, was given ownership of 22.5% of BioPort's stock without investing any money. Crowe's role at the company was to facilitate cooperation and good relations with government agencies and to secure military contracts from the Department of Defense.
After four years of constant factory violations that prevented the vaccine from being shipped, on December 13, 2001 the FDA began re-inspecting the BioPort anthrax facility in Lansing, MI. On January 14, 2002 The FDA issued a full approval of the facility, and on January 31 BioPort got final approval to distribute their anthrax vaccine.
BioPort's anthrax vaccine is quite controversial, with a great deal of debate about both its safety and efficacy.
Originally posted by ADVISOR
Might have to make an index list of all the threads which covered the subject, as many good peices of info where found and tied together.